AnalystsPaul Jeng
Paul Jeng's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 33%
#1717 out of 5209 analysts
Average Return
+51.88%
Win Rate
83%5 out of 6
Risk vs Reward
Poor
Good

Paul Jeng's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Context Therapeutics IncCNTX
+160.00%$1.00$2.60
2025-09-18 -
2026-03-04
Strong Buy
Adagene IncADAG
+54.21%$1.90$2.93
2025-11-24 -
2026-03-04
Strong Buy
Immatics NvIMTX
+54.01%$6.61$10.18
2025-09-18 -
2026-03-04
Strong Buy
Ideaya Biosciences IncIDYA
+32.27%$26.22$34.68
2025-09-18 -
2026-03-04
Strong Buy
Ideaya Biosciences IncIDYA
+12.16%$30.92$34.68
2026-02-18 -
2026-03-04
Strong Buy

Paul Jeng Analyst Color

Get additional color on Paul Jeng's coverage of popular stocks

Paul Jeng's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Ideaya Biosciences IncIDYA
2Strong Buy$50.00+44.18%Reiterates
15 days ago
Adagene IncADAG
1Strong Buy$9.00+207.17%Initiates Coverage On
3 months ago
Immatics NvIMTX
2Strong Buy$19.00+86.64%Maintains
4 months ago
Context Therapeutics IncCNTX
1Strong Buy$5.00+92.31%Initiates Coverage On
6 months ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.